New lithium formula could mean fewer side effects for brain disorders
Knowledge-focused
Completed
This early-stage study tests a new crystallized form of lithium (AL001) against standard lithium carbonate in 6 healthy adults. Participants take each drug for 14 days and undergo MRIs and blood draws to compare how much lithium reaches the brain. The goal is to see if AL001 is s…
Phase: PHASE1 • Sponsor: Alzamend Neuro, Inc. • Aim: Knowledge-focused
Last updated Jul 31, 2026 00:00 UTC